| CTRI Number |
CTRI/2023/08/056739 [Registered on: 22/08/2023] Trial Registered Prospectively |
| Last Modified On: |
22/08/2023 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Other (Specify) [Cosmetics ] |
| Study Design |
Other |
|
Public Title of Study
|
Skin Irritation test on The Good Karma Co skin and personal care products |
|
Scientific Title of Study
|
A Clinical study to evaluate the Irritation potential of the Good Karma Co Skin and personal care formulations on healthy human subjects. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| CCFT117 Version 1.0 Dated 27 July 2023 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Robin Chugh |
| Designation |
Principal Investigator |
| Affiliation |
CCFT Laboratories |
| Address |
1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road Meerut.
Meerut
UTTAR PRADESH
250002
India |
| Phone |
7078103723 |
| Fax |
|
| Email |
robinderm25@gmail.com |
|
Details of Contact Person
Scientific Query
|
| Name |
Puneet Mittal |
| Designation |
Clinical Research Consultant |
| Affiliation |
CCFT Laboratories |
| Address |
First Floor, Room 4, Clinical Research Dept, Mittal Building, 121-B Mansarovar Ind Estate, Panchli Khurd, Baghpat Road Meerut
Meerut
UTTAR PRADESH
250002
India |
| Phone |
8937015757 |
| Fax |
|
| Email |
puneetmittal@mgcts.org |
|
Details of Contact Person
Public Query
|
| Name |
Puneet Mittal |
| Designation |
Clinical Research Consultant |
| Affiliation |
CCFT Laboratories |
| Address |
First Floor, Room 4, Clinical Research Dept, Mittal Building, 121-B Mansarovar Ind Estate, Panchli Khurd, Baghpat Road Meerut
UTTAR PRADESH
250002
India |
| Phone |
8937015757 |
| Fax |
|
| Email |
puneetmittal@mgcts.org |
|
|
Source of Monetary or Material Support
|
| CCFT Laboratories, 135, Punjabipura, Delhi Road, Meerut, India |
| The Good Karma Co. PLOT NO 28 SECTOR 33 GURGAON, OPPOSITE INFOCITY II, Gurgaon, Gurugram-122003, Haryana, India |
|
|
Primary Sponsor
|
| Name |
The Good Karma Co |
| Address |
The Good Karma Co. PLOT NO 28 SECTOR 33 GURGAON, OPPOSITE INFOCITY II, Gurgaon, Gurugram-122003, Haryana, India |
| Type of Sponsor |
Pharmaceutical industry-Indian |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Not applicable |
Not applicable |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Robin Chugh |
CCFT laboratories |
1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road, Meerut
Meerut
UTTAR PRADESH |
7078103723
robinderm25@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| ARMHRC Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Not applicable. This is a Irritation Patch Test Study
|
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Finn chambers patch |
Each patch contains 0.04ml of 1. All Day Cream for Men 2. Hand and Foot Cream 3. Skin Renewal Cream
4. Body Cream with Lavender 5. Tea Tree Face Mist 6. Apple Cider Vinegar Face Toner 7. Under Eye Gel
8. Skin Brightening 9. Pore Cleansing Gel 10. Coconut milk & Oatmeal Body Scrub 11. Face Pack with Neem & Turmeric 12. Body Lotion 13. 10% Niacinamide Face Serum 14. Vitamin C Serum with Arbutin 15. Cleansing Make up Balm 16. Blue Berry Night Gel 17. Intimate Wash for Women
Route of Administration: Topical
Frequency: Once
Duration: 24 hours |
| Comparator Agent |
Not applicable |
Not applicable |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
1.Voluntary man/women between 18 and 65 years.
2. Photo type III to V.
3. Having apparently healthy skin on test area
4. For whom the investigator considers that the compliance will be correct.
5. Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures.
6. Having signed a Consent Form.
7. Willingness to avoid intense UV exposure on test site (sun or artificial UV), during the course of the study.
8. Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna…), during the course of the study.
9. Should be able to read and write (in English, Hindi or local language).
10. Having valid proof of identity and age. |
|
| ExclusionCriteria |
| Details |
1. Pregnant/nursing mothers
2. Scars, excessive terminal hair or tattoo on the studied area.
3. Henna tattoo anywhere on the body (in case of studies involving hair dyes).
4. Dermatological infection/pathology on the level of studied area. 5. Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye).
6. Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures.
7. Chronic illness which may influence the outcome of the study. 8. Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month).
9. Subject in an exclusion period or participating in another food,cosmetic or therapeutic trial. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Change in Skin Irritation Score-erythema & oedema |
Day 1,Day 2, Day 8 |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Not applicable |
Not applicable |
|
|
Target Sample Size
|
Total Sample Size="24"
Sample Size from India="24"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
29/08/2023 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0"
Months="0"
Days="15" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The below products would be tested as per the guideline IS405. 11 for dermal safety assessment.1. All Day Cream for Men- Cream 2. Hand and Foot Cream - Cream 3. Skin Renewal Cream - Cream 4. Body Cream with Lavender - Cream 5. Tea Tree Face Mist - Mist 6. Apple Cider Vinegar Face Toner - Toner 7. Under Eye Gel - Gel 8. Skin Brightening Gel - Gel 9. Pore Cleansing Gel - Gel 10. Coconut milk & Oatmeal Body Scrub- Scrub 11. Face Pack with Neem & Turmeric - Facepack 12. Body Lotion - Lotion 13. 10% Niacinamide Face Serum- Serum 14. Vitamin C Serum with Arbutin - Serum 15. Cleansing Make up Balm - 16. Blue Berry Night Gel - Gel 17. Intimate Wash for Women - Wash
|